- Paragon 28 Inc.
Paragon 28 Inc.
14445 Grasslands Drive
Website
Offer Price
Offer Size
3-Year Outlook
Volatility
1st Day Turnover
$16.00
7,800,000
Positive
High
55.72%
Offering Team
Deal Managers
- Bank of America Merrill Lynch
- Piper Jaffray
Lawyers
- Latham & Watkins LLP
Auditors
- Deloitte & Touche LLP
Pre-IPO Investors
Investors
- Google Ventures
- Intel Ventures
- Patricoff Ventures
- Kleiner Perkins
Pre-IPO Holdings(%)
- 30
- 20
- 05
- 18
Deal Highlights
Our mission is to continuously improve the outcomes and experiences of people suffering from foot and ankle conditions. We are a leading medical device company exclusively focused on the foot and ankle orthopedic market and we are dedicated to improving patient lives. Our innovative orthopedic solutions, procedural approaches and instrumentation cover a wide range of foot and ankle ailments including fracture fixation, hallux valgus (bunions), hammertoe, ankle, progressive More
Deal Tracker
Investors
Filing
14 Oct, 2021Offer
15 Oct, 2021Look Ahead
Lock Up Expiry
15 Apr, 2022Earning
Nov 1, 2018IPO Terms
Offer Price | $16.00 |
Offer Size | 7M |